| Theresa Mcclain, DO | |
|
1611 Pond Rd Ste 300, Allentown, PA 18104 | |
| (610) 398-7700 | |
| (610) 398-3917 |
| Full Name | Theresa Mcclain |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 1611 Pond Rd Ste 300, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235573916 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS018924 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Medical Center | Reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Joseph Medical Group | 3779688650 | 171 |
News Archive
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
High-calorie, energy-dense foods are constantly available in our modern society. Researchers at the Max Planck Institute for Metabolism Research in Cologne have discovered that a group of nerve cells in the brains of mice promotes the consumption of high-fat food.
› Verified 1 days ago
| Entity Name | St Joseph Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184754657 PECOS PAC ID: 3779688650 Enrollment ID: O20070421000011 |
News Archive
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
High-calorie, energy-dense foods are constantly available in our modern society. Researchers at the Max Planck Institute for Metabolism Research in Cologne have discovered that a group of nerve cells in the brains of mice promotes the consumption of high-fat food.
› Verified 1 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
High-calorie, energy-dense foods are constantly available in our modern society. Researchers at the Max Planck Institute for Metabolism Research in Cologne have discovered that a group of nerve cells in the brains of mice promotes the consumption of high-fat food.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Mcclain, DO 2494 Bernville Rd, Ste 100, Reading, PA 19605-9466 Ph: (610) 378-2899 | Theresa Mcclain, DO 1611 Pond Rd Ste 300, Allentown, PA 18104 Ph: (610) 398-7700 |
News Archive
Sperm in the first fraction of ejaculate are more numerous, move more and present better quality DNA than those lagging behind. This is the conclusion of a study led by the Ginemed fertility clinic, which confirms that while the objective of the first fraction is to fertilise the egg, the second phase is so that no sperm from any other male has a chance to fertilise it.
Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan.
GlaxoSmithKline (GSK) and Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (Impax), today announced an agreement for the development and commercialization of IPX066, Impax's novel extended release carbidopa-levodopa product, outside the United States and Taiwan. IPX066, an investigational product under development for the treatment of Parkinson's Disease (PD), is currently in Phase III clinical trials.
Research published in the November issue of Anesthesiology describes development of a new Risk Stratification Index (RSI) that allows important clinical outcomes such as length-of-stay and mortality for surgical patients to be accurately compared among hospitals using only publically available billing data. The new risk stratification system is more accurate than existing outcomes measurements such as the Charlson Comorbidity Index (CCI) and the investigators have made it freely available.
High-calorie, energy-dense foods are constantly available in our modern society. Researchers at the Max Planck Institute for Metabolism Research in Cologne have discovered that a group of nerve cells in the brains of mice promotes the consumption of high-fat food.
› Verified 1 days ago
Dr. Rachel O'connell, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 Cetronia Rd Ste 120, Allentown, PA 18104 Phone: 845-262-5204 | |
Treasure Ngozi Ada Walker, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1245 S Cedar Crest Blvd Ste 201, Allentown, PA 18103 Phone: 610-402-4870 Fax: 610-402-4960 | |
Dr. Timothy M Pellini, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1245 S Cedar Crest Blvd, Suite 201, Allentown, PA 18103 Phone: 610-437-1931 Fax: 610-433-8791 | |
Shirin Azadi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1627 Chew St, Allentown, PA 18102 Phone: 610-402-6000 | |
Dr. Salam Syed, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-8000 | |
Jennifer Melanie Heibig, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 610-402-5100 | |
Dahlia Kronfli, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1628 Chew St, Allentown, PA 18102 Phone: 610-402-1600 |